SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-12-004040
Filing Date
2012-04-23
Accepted
2012-04-23 08:00:24
Documents
10
Period of Report
2012-06-05
Effectiveness Date
2012-04-23

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 14A pdlbio_def14a-060512.htm DEF 14A 1043057
2 logo.jpg GRAPHIC 15637
3 mclaughlin.jpg GRAPHIC 6372
4 proxy1.jpg GRAPHIC 292796
5 proxy2.jpg GRAPHIC 288742
6 proxy3.jpg GRAPHIC 165990
7 proxy4.jpg GRAPHIC 294767
8 proxy5.jpg GRAPHIC 72021
9 proxy6.jpg GRAPHIC 17351
10 stone.jpg GRAPHIC 6093
  Complete submission text file 0001437749-12-004040.txt   2643129
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-19756 | Film No.: 12771982
SIC: 2836 Biological Products, (No Diagnostic Substances)